1. A circular mapping catheter is not mandatory for isolating pulmonary veins during paroxysmal atrial fibrillation ablation with radiofrequency
- Author
-
Fabien Dormal, Dominique Blommaert, Olivier Xhaet, Benoit Robaye, Benoit Collet, Veronique Godeaux, Elisabeth Ballant, Olivier Deceuninck, Maximilien Gourdin, Florence Huys, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service de cardiologie, UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (MGD) Service d'anesthésiologie, and UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire
- Subjects
medicine.medical_specialty ,Catheters ,Paroxysmal atrial fibrillation ,Radiofrequency ablation ,medicine.medical_treatment ,Ablation ,030204 cardiovascular system & hematology ,Pulmonary vein ,law.invention ,Circular mapping catheter ,03 medical and health sciences ,0302 clinical medicine ,Recurrence ,law ,Physiology (medical) ,Swing-fall technique ,Atrial Fibrillation ,medicine ,Humans ,Fluoroscopy ,030212 general & internal medicine ,Atrial tachycardia ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Atrial fibrillation ,medicine.disease ,Surgery ,Catheter ,Treatment Outcome ,3D mapping ,Pulmonary Veins ,Catheter Ablation ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
PURPOSE: In this study, we evaluated the feasibility, efficacy, and safety of radiofrequency ablation of paroxysmal atrial fibrillation (AF) with the use of an ablation catheter only (non-CMC group) by retrospectively comparing its procedural success and recurrence rates at 1 year to ablation performed with the help of a circular mapping catheter (CMC group). METHODS: We compared the success and recurrence rates between 226 patients and 251 patients who underwent index ablation with and without the use of CMC, respectively. RESULTS: Freedom from recurrence was defined as a 1-year absence of AF/atrial tachycardia (AT) episodes > 30 s, beyond the 3-month blanking period. There was no significant difference between the number of pulmonary vein isolations, recurrence rate of AF/AT, and the use of antiarrhythmic drugs after 1 year of ablation. The procedure and fluoroscopy times were lower in the non-CMC group compared with the CMC group (106 ± 33 vs. 125 ± 32 min, p < 0.0001; 2.2 ± 1.9 vs. 2.7 ± 2.3 min, p = 0.0002, respectively). CONCLUSIONS: Pulmonary vein isolation without the use of a CMC is feasible; moreover, the material costs, procedure time, and radiation exposure were reduced compared with the CMC group. Freedom of recurrence was similar between groups. Optimized use of 3D electro-anatomical mapping systems could reduce the radiation exposure for both the patient and physician.
- Published
- 2020
- Full Text
- View/download PDF